8583 Results
2

Business Courier: UC part of nearly $2M CDC grant to develop next generation of health care PPE

November 10, 2021

UC researchers are taking part in a new nearly $2 million, multiyear study that will help develop a new generation of PPE, or personal protective equipment, for health care workers. UC researchers will work with teams from Iowa State University and the University of California-Davis to improve the design, function and safety of PPE, or personal protective equipment, the university said in a release this week. The study is part of a multi-institutional, four-year grant worth $1.8 million from the Centers for Disease Control and Prevention. The Cincinnati Business Courier published a story on the research.

3

Atlanta Journal Constitution: Ointment kills antibiotic-resistant bacteria, promotes wound healing

December 3, 2021

The Atlanta Journal Constitution published a story on research at the University of Cincinnati College of Medicine possibly adding a weapon to hospitals’ bacteria fighting arsenal.Using the topical drug called AB569 — a combination of acidified nitrite and ethylenediaminetetraacetic acid — promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries, the study found. The study was published in the journal Infection and Immunity.

5

Cincinnati.com: COVID-19 in Ohio: What we know so far about the newest 'variant of concern,' called omicron

November 29, 2021

Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

6

Medscape: Etiological differences underlie five subtypes of Type 2 diabetes

November 19, 2021

In a story for Reuters Health published by Medscape, it was reported that Type 2 diabetes subtypes have partially distinct genetic backgrounds, suggesting etiological differences that may one day be targeted for treatment. That was the conclusion of genome-wide association analyses. Shailendra Patel, MD, PhD, professor and director of the Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine provided reaction to the study.

7

WVXU: Recounting the similarities between the 1918 influenza pandemic and coronavirus

March 9, 2022

COVID-19 first entered the public consciousness about two years ago. It drew a lot of comparisons to another pandemic just over a hundred years earlier. WVXU interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to learn more about how the COVID-19 outbreak compares with the 1918 influenza outbreak.

8

WVXU: 'Springing' forward means more daylight but also more health problems and less sleep

March 14, 2022

A Congressional committee heard testimony this week on the pros and cons of switching between standard and daylight saving time. Many people say they like having the extra hour of daylight, but sleep professionals say it's a bad idea. The American Academy of Sleep Medicine is continuing the push to abolish daylight saving time. Research shows most people get an hour less sleep on daylight saving time. That has a host of health and safety implications. In a story posted by WVXU, Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine and director of the Sleep Medicine Center at UC Medical Center, said the time change creates the potential for a variety of health problems.

9

Healthline: New HIV variant discovered: May be more infectious and severe

February 7, 2022

New research from the University of Oxford finds a new variant of HIV, the virus that causes AIDS, that is potentially more infectious and could more seriously affect the immune system. So far, 109 people, most of whom live in the Netherlands, have the variant. In a story published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited reacting to this new variant.

10

55KRC: UC expert discusses ADHD

July 26, 2022

The University of Cincinnati's Jenni E. Farrow, MD, was featured in a segment on 55KRC's Simply Medicine program to discuss ADHD.